uniQure (QURE) Total Current Liabilities (2015 - 2026)
uniQure's (QURE) quarterly Total Current Liabilities came in at $59.2 million in Q1 2026, up 63.03% year-on-year from $36.3 million in Q1 2025, and down 5.92% quarter-over-quarter from $62.9 million in Q4 2025.
uniQure (QURE) Total Current Liabilities (2015 - 2026) Analysis & Trends
uniQure's Total Current Liabilities history runs 12 years deep, the most recent figure standing at $59.2 million for Q1 2026.
- On a quarterly basis, Total Current Liabilities rose 63.03% year-over-year to $59.2 million in Q1 2026; TTM through Mar 2026 was $59.2 million, a 63.03% increase from a year earlier, with the FY2025 full-year figure at $62.9 million, up 57.09% from the prior year.
- Total Current Liabilities retreated to $59.2 million in Q1 2026 per QURE's latest filing, from $62.9 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $100.6 million in Q3 2025 and bottomed at $36.3 million in Q1 2025.
- The 5-year median for Total Current Liabilities is $64.0 million (2022), against an average of $62.7 million.
- Across the five-year window, Total Current Liabilities jumped 106.51% in 2022 and slumped 49.14% in 2025, its largest moves.
- Year by year, Total Current Liabilities stood at $75.9 million in 2022, then fell by 2.96% to $73.7 million in 2023, then plunged by 45.64% to $40.1 million in 2024, then surged by 57.09% to $62.9 million in 2025, then retreated by 5.92% to $59.2 million in 2026.
- Per Business Quant, the three latest QURE Total Current Liabilities figures stand at $59.2 million (Q1 2026), $62.9 million (Q4 2025), and $100.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 56.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 66.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.81 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 6.38 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 3.88 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.11 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 289.60 Mn |
| 10 | uniQure | 2.47 Bn | 2.47 Bn | 3.34 Mn | 59.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.20 Mn |
| Dec 31, 2025 | 62.92 Mn |
| Sep 30, 2025 | 100.63 Mn |
| Jun 30, 2025 | 40.93 Mn |
| Mar 31, 2025 | 36.31 Mn |
| Dec 31, 2024 | 40.05 Mn |
| Sep 30, 2024 | 71.27 Mn |
| Jun 30, 2024 | 80.47 Mn |
| Mar 31, 2024 | 63.47 Mn |
| Dec 31, 2023 | 73.68 Mn |
| Sep 30, 2023 | 68.61 Mn |
| Jun 30, 2023 | 68.36 Mn |
| Mar 31, 2023 | 66.34 Mn |
| Dec 31, 2022 | 75.92 Mn |
| Sep 30, 2022 | 63.97 Mn |
| Jun 30, 2022 | 48.26 Mn |
| Mar 31, 2022 | 44.70 Mn |
| Dec 31, 2021 | 36.76 Mn |
| Sep 30, 2021 | 41.92 Mn |
| Jun 30, 2021 | 46.10 Mn |